UY27929A1 - Composiciones farmaceuticas de farmacos semiordenados y polimeros - Google Patents
Composiciones farmaceuticas de farmacos semiordenados y polimerosInfo
- Publication number
- UY27929A1 UY27929A1 UY27929A UY27929A UY27929A1 UY 27929 A1 UY27929 A1 UY 27929A1 UY 27929 A UY27929 A UY 27929A UY 27929 A UY27929 A UY 27929A UY 27929 A1 UY27929 A1 UY 27929A1
- Authority
- UY
- Uruguay
- Prior art keywords
- semiordened
- pharmaceutical compositions
- polymer drugs
- polymer
- drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Abstract
Una composición sólida de un fármaco de baja solubilidad y un polímero potenciador de la concentración tiene una porción del fármaco en un estado semiordenado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40308702P | 2002-08-12 | 2002-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27929A1 true UY27929A1 (es) | 2004-03-31 |
Family
ID=31715934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27929A UY27929A1 (es) | 2002-08-12 | 2003-08-05 | Composiciones farmaceuticas de farmacos semiordenados y polimeros |
Country Status (24)
Country | Link |
---|---|
US (2) | US8257739B2 (es) |
EP (2) | EP1530457B1 (es) |
JP (1) | JP2006500349A (es) |
CN (1) | CN1681479A (es) |
AR (1) | AR040969A1 (es) |
AT (1) | ATE442130T1 (es) |
AU (1) | AU2003249474A1 (es) |
BR (1) | BR0313428A (es) |
CA (1) | CA2496441C (es) |
DE (1) | DE60329188D1 (es) |
ES (1) | ES2333318T3 (es) |
GT (1) | GT200300170A (es) |
IL (1) | IL166411A0 (es) |
MX (1) | MXPA05000977A (es) |
NO (1) | NO20050419L (es) |
PA (1) | PA8579801A1 (es) |
PE (1) | PE20040865A1 (es) |
PL (1) | PL375345A1 (es) |
PT (1) | PT1530457E (es) |
RU (1) | RU2005103625A (es) |
TW (1) | TW200406224A (es) |
UY (1) | UY27929A1 (es) |
WO (1) | WO2004014342A1 (es) |
ZA (1) | ZA200500470B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001034119A2 (en) * | 1999-11-12 | 2001-05-17 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
EP1404300B1 (en) * | 2001-06-22 | 2009-09-30 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
US8025899B2 (en) * | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
CA2577852A1 (en) * | 2004-08-31 | 2006-03-09 | Pfizer Products Inc. | Pharmaceutical dosage forms comprising a low-solubility drug and a polymer |
EP1855652B1 (en) | 2005-01-28 | 2015-12-02 | Bend Research, Inc | Drying of drug-containing particles |
EP2043610B1 (en) | 2006-07-21 | 2015-07-01 | Bend Research, Inc. | Drying of drug-containing particles |
JP5328643B2 (ja) * | 2007-04-20 | 2013-10-30 | 大同化成工業株式会社 | 新規乾式固体分散体用基剤、該基剤を含有する固体分散体及び該分散体を含有する組成物 |
US20100048913A1 (en) | 2008-03-14 | 2010-02-25 | Angela Brodie | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
BRPI1008745A2 (pt) | 2009-02-05 | 2019-09-17 | Tokai Pharmaceuticals Inc | pró-fármacos de inibidores esteroidais de cyp17/antiandrogênios |
EP2366378A1 (en) | 2010-03-01 | 2011-09-21 | Dexcel Pharma Technologies Ltd. | Sustained-release donepezil formulations |
WO2012122279A1 (en) | 2011-03-08 | 2012-09-13 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
AR087277A1 (es) * | 2011-07-21 | 2014-03-12 | Bristol Myers Squibb Co | Composiciones biodisponibles de compuestos amorfos de piperidinilo, composicion farmaceutica, metodos |
EP2964203B1 (en) | 2013-03-07 | 2019-04-03 | Dow Global Technologies LLC | Novel esterified cellulose ethers of very high molecular weight |
KR102110120B1 (ko) | 2013-03-07 | 2020-05-14 | 다우 글로벌 테크놀로지스 엘엘씨 | 저점도의 신규한 에스테르화된 셀룰로스 에테르 |
WO2014137778A1 (en) | 2013-03-07 | 2014-09-12 | Dow Global Technologies Llc | Novel esterified cellulose ethers of very low viscosity |
SG11201507093WA (en) | 2013-03-14 | 2015-10-29 | Univ Maryland Baltimore Office Of Technology Transfer | Androgen receptor down-regulating agents and uses thereof |
EP2832723B1 (en) * | 2013-07-29 | 2017-02-15 | Zentiva, a.s. | Stabilised amorphous forms of Saxagliptin |
CN105636594A (zh) | 2013-08-12 | 2016-06-01 | 托凯药业股份有限公司 | 使用雄激素靶向疗法用于治疗肿瘤性疾病的生物标记物 |
CA2962719A1 (en) | 2014-10-31 | 2016-05-06 | Bend Research Inc. | Process for forming active domains dispersed in a matrix |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1146866A (en) | 1979-07-05 | 1983-05-24 | Yamanouchi Pharmaceutical Co. Ltd. | Process for the production of sustained release pharmaceutical composition of solid medical material |
DE3438830A1 (de) | 1984-10-23 | 1986-04-30 | Rentschler Arzneimittel | Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung |
DE3612212A1 (de) | 1986-04-11 | 1987-10-15 | Basf Ag | Verfahren zur herstellung von festen pharmazeutischen formen |
JPS6314724A (ja) * | 1986-07-08 | 1988-01-21 | Tooa Eiyoo Kk | プラゾシン製剤 |
JPH02149518A (ja) * | 1988-11-30 | 1990-06-08 | Nikken Chem Co Ltd | 経口投与用薬剤 |
DK546289D0 (da) * | 1989-11-02 | 1989-11-02 | Danochemo As | Carotenoidpulvere |
US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US5552160A (en) * | 1991-01-25 | 1996-09-03 | Nanosystems L.L.C. | Surface modified NSAID nanoparticles |
EP0580860B2 (en) | 1991-04-16 | 2004-12-15 | Nippon Shinyaku Company, Limited | Method of manufacturing solid dispersion |
DE4140185C2 (de) * | 1991-12-05 | 1996-02-01 | Alfatec Pharma Gmbh | Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung |
DE4140184C2 (de) * | 1991-12-05 | 1995-12-21 | Alfatec Pharma Gmbh | Akutform für ein Flurbiprofen enthaltendes Arzneimittel |
US5876754A (en) * | 1992-01-17 | 1999-03-02 | Alfatec-Pharma Gmbh | Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies |
US5340591A (en) | 1992-01-24 | 1994-08-23 | Fujisawa Pharmaceutical Co., Ltd. | Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine |
JP3265680B2 (ja) | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | 経口製剤用組成物 |
US5811547A (en) * | 1992-10-14 | 1998-09-22 | Nippon Shinyaju Co., Ltd. | Method for inducing crystalline state transition in medicinal substance |
US5916596A (en) * | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
DE4316537A1 (de) | 1993-05-18 | 1994-11-24 | Basf Ag | Zubereitungen in Form fester Lösungen |
JP3345761B2 (ja) * | 1993-06-16 | 2002-11-18 | 日本特殊陶業株式会社 | ヒーター付スパークプラグ及びその製造方法 |
DE4327063A1 (de) | 1993-08-12 | 1995-02-16 | Kirsten Dr Westesen | Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften |
DE4329446A1 (de) * | 1993-09-01 | 1995-03-02 | Basf Ag | Verfahren zur Herstellung von feinteiligen Farb- oder Wirkstoffzubereitungen |
DE19509807A1 (de) * | 1995-03-21 | 1996-09-26 | Basf Ag | Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen |
TW384224B (en) * | 1994-05-25 | 2000-03-11 | Nano Sys Llc | Method of preparing submicron particles of a therapeutic or diagnostic agent |
US5685331A (en) | 1994-12-20 | 1997-11-11 | Ac & R Components, Inc. | Oil level regulator |
US5585108A (en) * | 1994-12-30 | 1996-12-17 | Nanosystems L.L.C. | Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays |
US5662883A (en) * | 1995-01-10 | 1997-09-02 | Nanosystems L.L.C. | Microprecipitation of micro-nanoparticulate pharmaceutical agents |
US5560932A (en) * | 1995-01-10 | 1996-10-01 | Nano Systems L.L.C. | Microprecipitation of nanoparticulate pharmaceutical agents |
US5716642A (en) * | 1995-01-10 | 1998-02-10 | Nano Systems L.L.C. | Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents |
US5665331A (en) * | 1995-01-10 | 1997-09-09 | Nanosystems L.L.C. | Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers |
US5569448A (en) * | 1995-01-24 | 1996-10-29 | Nano Systems L.L.C. | Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions |
US5560931A (en) * | 1995-02-14 | 1996-10-01 | Nawosystems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
US5571536A (en) * | 1995-02-06 | 1996-11-05 | Nano Systems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
US5622938A (en) * | 1995-02-09 | 1997-04-22 | Nano Systems L.L.C. | Sugar base surfactant for nanocrystals |
US5534270A (en) * | 1995-02-09 | 1996-07-09 | Nanosystems Llc | Method of preparing stable drug nanoparticles |
US5518738A (en) * | 1995-02-09 | 1996-05-21 | Nanosystem L.L.C. | Nanoparticulate nsaid compositions |
US5591456A (en) * | 1995-02-10 | 1997-01-07 | Nanosystems L.L.C. | Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer |
US5573783A (en) * | 1995-02-13 | 1996-11-12 | Nano Systems L.L.C. | Redispersible nanoparticulate film matrices with protective overcoats |
US5510118A (en) * | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
DE19504832A1 (de) | 1995-02-14 | 1996-08-22 | Basf Ag | Feste Wirkstoff-Zubereitungen |
US5580579A (en) * | 1995-02-15 | 1996-12-03 | Nano Systems L.L.C. | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
US5565188A (en) * | 1995-02-24 | 1996-10-15 | Nanosystems L.L.C. | Polyalkylene block copolymers as surface modifiers for nanoparticles |
US5718919A (en) * | 1995-02-24 | 1998-02-17 | Nanosystems L.L.C. | Nanoparticles containing the R(-)enantiomer of ibuprofen |
DE19509806A1 (de) * | 1995-03-21 | 1996-09-26 | Basf Ag | Lagerstabile Arzneiformen |
DE19509805A1 (de) | 1995-03-21 | 1996-09-26 | Basf Ag | Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica |
EP0862420A4 (en) | 1995-10-13 | 1999-11-03 | Penn State Res Found | SYNTHESIS OF DRUG SPRAY DRUG NANOPARTICLES |
US5833891A (en) * | 1996-10-09 | 1998-11-10 | The University Of Kansas | Methods for a particle precipitation and coating using near-critical and supercritical antisolvents |
US5874029A (en) * | 1996-10-09 | 1999-02-23 | The University Of Kansas | Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent |
JPH09309828A (ja) * | 1996-03-18 | 1997-12-02 | Eisai Co Ltd | 溶解を改善した薬剤組成物 |
IL117773A (en) * | 1996-04-02 | 2000-10-31 | Pharmos Ltd | Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability |
JPH107558A (ja) * | 1996-06-19 | 1998-01-13 | Eisai Co Ltd | 溶解性改善製剤 |
DE19629753A1 (de) * | 1996-07-23 | 1998-01-29 | Basf Ag | Verfahren zur Herstellung von festen Arzneiformen |
DE19637517A1 (de) * | 1996-09-13 | 1998-03-19 | Basf Ag | Herstellung von pulverförmigen, kaltwasserdispergierbaren Carotinoid-Zubereitungen und die Verwendung der neuen Carotinoid-Zubereitungen |
US6045829A (en) * | 1997-02-13 | 2000-04-04 | Elan Pharma International Limited | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
WO1998038167A1 (en) | 1997-02-26 | 1998-09-03 | Pfizer Inc. | Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
US6126451A (en) | 1997-06-02 | 2000-10-03 | Compaq Computer Corporation | SCSI connector |
ES2287971T3 (es) * | 1997-08-11 | 2007-12-16 | Pfizer Products Inc. | Dispersiones farmaceuticas solidas con biodisponibilidad incrementada. |
HN1998000115A (es) * | 1997-08-21 | 1999-06-02 | Warner Lambert Co | Formas de dosificación farmacéuticas sólidas |
DE69932920T2 (de) | 1998-02-05 | 2007-02-08 | Pfizer Products Inc., Groton | Neue dihydroxyhexansäurederivate |
US6350786B1 (en) | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
DE60039802D1 (de) * | 1999-02-10 | 2008-09-25 | Pfizer Prod Inc | Vorrichtung mit matrixgesteuerter Wirkstofffreisetzung |
ATE400252T1 (de) | 1999-02-10 | 2008-07-15 | Pfizer Prod Inc | Pharmazeutische feste dispersionen |
AP2002002552A0 (en) * | 1999-12-23 | 2002-06-30 | Pfizer Prod Inc | Pharmaceutical compositions providing enhanced drug concentrations. |
AR028253A1 (es) * | 2000-03-16 | 2003-04-30 | Pfizer Prod Inc | Inhibidores de la glucogeno fosforilasa |
US7115279B2 (en) * | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
JP2004534811A (ja) * | 2001-06-22 | 2004-11-18 | ファイザー・プロダクツ・インク | ポリマーと薬剤の集合体を含む医薬組成物 |
BR0210520A (pt) * | 2001-06-22 | 2004-06-22 | Pfizer Prod Inc | Composições farmacêuticas de dispersões de fármacos amorfos misturados com polìmeros |
EP1269994A3 (en) * | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
JP2005507393A (ja) | 2001-09-28 | 2005-03-17 | ソルベスト リミテッド | 親水性活性物質および疎水性活性物質の水溶性ナノ粒子 |
US6878693B2 (en) * | 2001-09-28 | 2005-04-12 | Solubest Ltd. | Hydrophilic complexes of lipophilic materials and an apparatus and method for their production |
US6848693B2 (en) * | 2001-11-20 | 2005-02-01 | Actuant Corporation | Pseudo four-leg vehicle leveling system with independent leg lock-out |
RU2278659C9 (ru) * | 2002-02-01 | 2007-02-20 | Пфайзер Продактс Инк. | Способ получения гомогенных, высушенных распылением твердых аморфных дисперсий лекарственного средства с использованием модифицированной установки сушки распылением |
BRPI0417492A (pt) * | 2003-12-09 | 2007-05-29 | Pfizer | composições compreendendo um inibidor de protease de hiv |
-
2003
- 2003-07-31 AT AT03784384T patent/ATE442130T1/de not_active IP Right Cessation
- 2003-07-31 AU AU2003249474A patent/AU2003249474A1/en not_active Abandoned
- 2003-07-31 CA CA2496441A patent/CA2496441C/en not_active Expired - Fee Related
- 2003-07-31 WO PCT/IB2003/003465 patent/WO2004014342A1/en active Application Filing
- 2003-07-31 CN CNA038213486A patent/CN1681479A/zh active Pending
- 2003-07-31 ES ES03784384T patent/ES2333318T3/es not_active Expired - Lifetime
- 2003-07-31 JP JP2004527196A patent/JP2006500349A/ja active Pending
- 2003-07-31 RU RU2005103625/15A patent/RU2005103625A/ru not_active Application Discontinuation
- 2003-07-31 PL PL03375345A patent/PL375345A1/xx not_active Application Discontinuation
- 2003-07-31 EP EP03784384A patent/EP1530457B1/en not_active Revoked
- 2003-07-31 EP EP09007816.3A patent/EP2111856A3/en not_active Withdrawn
- 2003-07-31 BR BR0313428-8A patent/BR0313428A/pt not_active Withdrawn
- 2003-07-31 PT PT03784384T patent/PT1530457E/pt unknown
- 2003-07-31 MX MXPA05000977A patent/MXPA05000977A/es unknown
- 2003-07-31 DE DE60329188T patent/DE60329188D1/de not_active Expired - Lifetime
- 2003-08-05 UY UY27929A patent/UY27929A1/es not_active Application Discontinuation
- 2003-08-05 US US10/636,834 patent/US8257739B2/en active Active
- 2003-08-06 GT GT200300170A patent/GT200300170A/es unknown
- 2003-08-06 PA PA20038579801A patent/PA8579801A1/es unknown
- 2003-08-08 PE PE2003000793A patent/PE20040865A1/es not_active Application Discontinuation
- 2003-08-11 AR ARP030102902A patent/AR040969A1/es not_active Application Discontinuation
- 2003-08-11 TW TW092121979A patent/TW200406224A/zh unknown
-
2005
- 2005-01-18 ZA ZA200500470A patent/ZA200500470B/xx unknown
- 2005-01-20 IL IL16641105A patent/IL166411A0/xx unknown
- 2005-01-25 NO NO20050419A patent/NO20050419L/no not_active Application Discontinuation
-
2012
- 2012-08-23 US US13/593,263 patent/US8491933B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20120322805A1 (en) | 2012-12-20 |
AR040969A1 (es) | 2005-04-27 |
PT1530457E (pt) | 2009-11-06 |
PL375345A1 (en) | 2005-11-28 |
WO2004014342A1 (en) | 2004-02-19 |
CA2496441C (en) | 2010-03-16 |
RU2005103625A (ru) | 2005-08-20 |
EP2111856A3 (en) | 2014-09-10 |
ZA200500470B (en) | 2006-07-26 |
JP2006500349A (ja) | 2006-01-05 |
EP1530457A1 (en) | 2005-05-18 |
DE60329188D1 (de) | 2009-10-22 |
ES2333318T3 (es) | 2010-02-19 |
TW200406224A (en) | 2004-05-01 |
US20040156905A1 (en) | 2004-08-12 |
US8257739B2 (en) | 2012-09-04 |
AU2003249474A1 (en) | 2004-02-25 |
GT200300170A (es) | 2004-05-12 |
IL166411A0 (en) | 2006-01-15 |
EP2111856A2 (en) | 2009-10-28 |
ATE442130T1 (de) | 2009-09-15 |
PA8579801A1 (es) | 2004-02-16 |
MXPA05000977A (es) | 2005-05-16 |
US8491933B2 (en) | 2013-07-23 |
CN1681479A (zh) | 2005-10-12 |
NO20050419L (no) | 2005-04-04 |
CA2496441A1 (en) | 2004-02-19 |
PE20040865A1 (es) | 2004-11-25 |
EP1530457B1 (en) | 2009-09-09 |
BR0313428A (pt) | 2005-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY27929A1 (es) | Composiciones farmaceuticas de farmacos semiordenados y polimeros | |
CY1120377T1 (el) | Στερεη φαρμακευτικη δοσολογικη φαρμακοτεχνικη μορφη που περιεχει λοπιναβιρη | |
DK1543063T3 (da) | Medikament levering | |
CR7171A (es) | Composiciones farmaceuticas de farmacos y polimeros acidos neutralizados | |
PA8548801A1 (es) | Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco | |
CL2003002277A1 (es) | Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente. | |
EA200401252A1 (ru) | Микрочастицы лекарственных веществ | |
RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
CY1112268T1 (el) | Σκευασμα δισκιου παρατεταμενης αποδεσμευσης περιεχον πραμιπεξολη ή ενα φαρμακευτικως αποδεκτο αλας αυτης | |
ATE413162T1 (de) | Pharmazeutische zusammensetzungen zur sicheren verabreichung von bei der behandlung von drogenabhängigkeit verwendeten arzneimitteln | |
EA200602137A1 (ru) | Гидрогелевые препараты интерферона | |
DE60327103D1 (de) | Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer | |
DE60327693D1 (de) | Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff | |
HRP20080178T3 (en) | Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances | |
HRP20070291T3 (en) | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis | |
AR039232A1 (es) | Una formulacion farmaceutica que comprende al menos un compuesto seleccionado del grupo formado por hipnoticos no barbituricos y no benzodiacepinicos, y melatonina | |
EA200501301A1 (ru) | Ментоловые растворы лекарственных препаратов | |
ATE344223T1 (de) | Vitamin d-analoge | |
SE0001916D0 (sv) | Novel formulation | |
DE60111503D1 (de) | Pharmazeutische zusammensetzungen enthaltend terbinafin | |
FR2846327B1 (fr) | Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant. | |
BR0206960A (pt) | Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose | |
DOP2003000689A (es) | Composiciones farmaceuticas de farmacos semiordenados y polimeros | |
DK1273301T3 (da) | Farmaceutiske præparater baseret på aktive bestanddele der kan anvendes til ulovlig administration | |
SE0203817D0 (sv) | New composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150519 |